NIH collaboration helps advance potential Zika treatments
Researchers at the National Center for Advancing Translational Sciences (NCATS) recently identified compounds that potentially can be used to inhibit Zika virus replication and reduce its ability to kill brain cells. These compounds now can be studied by the broader research community to help combat the Zika public health crisis. NCATS is part of the National Institutes of Health.
NCATS researcher dispenses Zika virus into trays for compound screening.
This page was last updated on Friday, January 21, 2022